Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007

Dateline City:

WHITEHOUSE STATION, N.J.

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced the appointment of Robert M. Davis, 47, as executive
vice president and chief financial officer, effective April 23, 2014.
Davis, who will also oversee corporate strategy and corporate business
development, will succeed Peter N. Kellogg, 58.
Language:

English

Contact:

MerckMedia:Steven Cragle, 908-423-3461Pam Eisele, 267-305-3558orInvestors:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088

Ticker Slug:

Ticker: MRK Exchange: NYSE

read more

Source: Merck.com - Corporate News - March 27, 2014 Category: Pharmaceuticals Tags: Corporate News Latest News Source Type: news